Everest Organics spurts as board to mull fund raising on Dec 10

Attention Investors

Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000. | Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors." | KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." | ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

- EQUITY
  EQUITY
  PRICE
  
  Gainers & Losers
  
  Advances & Declines
  
  New Highs & Lows
  
  Index Movers
  
  Only Buyers/Sellers
  
  Out/Under Performers
- NEWS
  CORPORATE ACTIONS
  
  Announcements
  
  Book Closure
  
  Board Meetings
  
  Bonus Issues
  
  Rights Issues
  
  De-Listed Shares
  
  Market Turnover
  
  Change of Name
  
  Split of Face Value
- OTHER MARKETS
  FII Investments
  
  MF Investments
  
  ADR Prices
  
  World Indices
  
  Forex
  
  CORPORATE INFO
- VOLUME
  VOLUME
  Value & Volume Toppers
  
  Unusual Volume
  
  Bulk & Block Deals
  
  Sector Watch
- ANALYSIS
  ANALYSIS
  52 Week High Low
  
  Live Indices
  
  Exchange Holidays
  
  Index Constituents
  
  Historical Returns
  
  Circuit Breakers
- IPO
  IPO
  
  Forthcoming Issues
  
  Open Issues
  
  Closed Issues
  
  New Listing
  
  Basis of Allotment
  
  Draft Prospectus
  
  New Issue Monitor
  
  Best Performers
  
  Know IPO's / FAQ's

05 February 2025 00:00:00

Adani Ports

1144.25

(1.60%)

Asian Paints

2275.65

(-3.38%)

Axis Bank

1013.40

(-0.20%)

Bajaj Finance

8509.85

(0.35%)

Bajaj Finserv

1796.35

(-0.98%)

Bharti Airtel

1660.60

(-0.04%)

HCL Technologi..

1712.80

(-1.20%)

HDFC Bank

1737.50

(0.89%)

Hind. Unilever

2390.40

(-2.03%)

ICICI Bank

1267.90

(-0.04%)

IndusInd Bank

1060.70

(1.20%)

Infosys

1897.10

(-0.11%)

ITC

448.25

(-1.59%)

Kotak Mah. Ban..

1911.45

(-0.98%)

Larsen & Toubr..

3384.40

(-1.72%)

M & M

3177.40

(-0.41%)

Maruti Suzuki

13094.20

(-0.12%)

Nestle India

2249.05

(-2.23%)

NTPC

319.55

(0.13%)

Power Grid Cor..

285.15

(-0.21%)

Reliance Indus..

1278.05

(-0.62%)

St Bk of India

766.10

(-1.68%)

Sun Pharma.Ind..

1753.40

(-0.77%)

Tata Motors

717.20

(0.91%)

Tata Steel

134.40

(0.75%)

TCS

4090.75

(-0.56%)

Tech Mahindra

1660.80

(0.08%)

Titan Company

3490.50

(-3.02%)

UltraTech Cem.

11584.85

(0.52%)

Zomato Ltd

231.25

(-1.39%)

	Equity Analysis

	News Analysis

	Corporate Actions

	Other Market

	Company Profile

Share Holding Pattern

Your results on : Equity | News | Company-News

Everest Organics spurts as board to mull fund raising on Dec 10	Share Back
(09 Dec 2024)
According to the regulatory filing, the board will discuss and approve a proposal to raise funds through the preferential allotment of equity shares or other securities, subject to necessary approvals, including those from shareholders and regulatory authorities. Additionally, the board will consider the appointment of Narayana Rao as an Independent Director of the company. The official announcement was made on Saturday, 07 December 2024. The company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries. The company commenced its commercial operations in the year 1993. It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. The company's standalone net profit surged to Rs 74 lakh in Q2 FY25 as against Rs 3 lakh posted in Q2 FY24. However revenue from operations fell 10.9% YoY to Rs 44.05 crore in the quarter ended 30 September 2024. As of 09 December 2024, the company’s market capitalization stood at Rs 135.64 crore on the BSE.
Top